Concussion Post Syndrome Recruiting Phase 0 Trials for Magnesium oxide (DB01377)

IndicationStatusPhase
DBCOND0093446 (Concussion Post Syndrome)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03475693A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in AdolescentsTreatment